Daniel Lampard - Science In Chief Director
| SIS Stock | 27.00 0.50 1.89% |
Director
Daniel Lampard is Chief Director of Science in Sport
| Age | 44 |
| Address | 16-18 Hatton Garden, London, United Kingdom, EC1N 8AT |
| Web | https://www.scienceinsport.com |
Science In Management Efficiency
The company has return on total asset (ROA) of (0.0801) % which means that it has lost $0.0801 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.3289) %, meaning that it generated substantial loss on money invested by shareholders. Science In's management efficiency ratios could be used to measure how well Science In manages its routine affairs as well as how well it operates its assets and liabilities. At present, Science In's Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Net Tangible Assets is expected to grow to about 13 M, whereas Other Current Assets are forecasted to decline to about 2.1 M.Similar Executives
| Found 12 records | DIRECTOR Age | ||
| Graham Lilley | GlobalData PLC | 41 | |
| Ola Nordbye | Kinnevik Investment AB | N/A | |
| Olivier Lechien | Ion Beam Applications | N/A | |
| Christopher Bischoff | Kinnevik Investment AB | 51 | |
| Andreas Bernstrom | Kinnevik Investment AB | 50 | |
| Magnus Jakobson | Kinnevik Investment AB | 48 | |
| Torun Litzen | Kinnevik Investment AB | 57 | |
| Tatiana Shalalvand | Kinnevik Investment AB | 37 | |
| Natalie Tydeman | Kinnevik Investment AB | 53 | |
| Thomas Canon | Ion Beam Applications | N/A | |
| Mathew CPA | Kinnevik Investment AB | 45 | |
| Christian Scherrer | Kinnevik Investment AB | N/A | |
Management Performance
| Return On Equity | -0.33 | ||||
| Return On Asset | -0.0801 |
Science in Sport Leadership Team
Elected by the shareholders, the Science In's board of directors comprises two types of representatives: Science In inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Science. The board's role is to monitor Science In's management team and ensure that shareholders' interests are well served. Science In's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Science In's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Bernadette UdeWetherell, Chief Officer | ||
| Christopher Welsh, CFO Director | ||
| Daniel Wright, Executive Chairman | ||
| Megan Blaylock, Chief Officer | ||
| Muna Khan, Chief Officer | ||
| Andy Bott, Chief Officer | ||
| Daniel Lampard, Chief Director | ||
| Stephen Moon, CEO Director | ||
| Stephen MBA, Executive Director |
Science Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Science In a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.33 | ||||
| Return On Asset | -0.0801 | ||||
| Profit Margin | (0.19) % | ||||
| Operating Margin | (0.07) % | ||||
| Current Valuation | 72.58 M | ||||
| Shares Outstanding | 230.23 M | ||||
| Shares Owned By Insiders | 17.09 % | ||||
| Shares Owned By Institutions | 68.37 % | ||||
| Price To Book | 2.29 X | ||||
| Price To Sales | 1.15 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Science Stock
Science In financial ratios help investors to determine whether Science Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Science with respect to the benefits of owning Science In security.